Health News Releases

February 19, 2014 11:00

STC Life Co., Ltd. Successfully Treats Patients With Parkinson's Disease at Stem Cell Research and Treatment Center

Stem cell research institute (http://goo.gl/RCJcFS) of STC Life Co., Ltd. (Chairman: KYE HO LEE, http://goo.gl/1P02lk) and 97.7 B&H Clinic (Director: WON JU JUNG) successfully completed mesenchymal st

February 18, 2014 17:00

Acerde Signs a Development Contract with a China-based Leader in Medical Imaging

Acerde, an innovative company specializing in the development of rotating anodes for X-ray tubes used in the medical imaging industry, today announced (i) the signature of a development contract with

February 17, 2014 16:40

Moberg Pharma and Menarini Extend Distribution Agreement for Kerasal Nail to South East Asia

Moberg Pharma AB (OMX: MOB) and Menarini Asia-Pacific, a member of the Menarini Group are pleased to announce that Menarini Asia-Pacific has been granted the exclusive rights to market and sell Kerasa

February 12, 2014 11:00

Nestlé Skin Health Is Created Targeting Global Skin Health Needs

Today, Nestlé S.A. (Nestlé) announced the creation of Nestlé Skin Health S.A., a global leader focused on meeting the world’s increasing skin health needs with a scientifically-proven broad range of i

February 10, 2014 20:00

SuperECG: Mobile 24H ECG with Samsung G S4 - Analyze Your Heart Rhythm with Your Phone

SuperECG.com has tested its 24 h ECG analysis service with Samsung smartphones. “It is now possible to do a proper 24 h ECG heart rhythm monitoring with a smartphone. We tested our HeartBug servic

February 07, 2014 12:00

22nd Century Group Files Annual Report and Provides Business Update

22nd Century Group, Inc. (OTCQB:XXII, http://goo.gl/7CavNZ) today announced that the Company filed its 2013 report on Form 10-K with the Securities and Exchange Commission. For year ended December

February 07, 2014 10:10

New Paper Indicates a Potential Fifty-Percent Reduction in Cardiac Events for Prostate Cancer Patients with Pre-Existing Cardiovascular Disease When Treated With FIRMAGON® (degarelix) Compared To LHRH Agonists

A paper published today in European Urology, the official journal of the European Association of Urology, indicates that the gonadotropin releasing hormone (GnRH) antagonist degarelix (brand name: FIR

February 05, 2014 14:10

TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis

TECFIDERA® (dimethyl fumarate) has been approved by the European Commission (EC) as a first-line oral treatment for people with relapsing-remitting multiple sclerosis (RRMS), the most common form of m

February 04, 2014 15:48

22nd Century Group Delivers Additional Proprietary Research Cigarettes with Various Nicotine Levels

22nd Century Group, Inc. (OTCQB: XXII, http://goo.gl/7CavNZ) today announced that Goodrich Tobacco Company, its wholly-owned subsidiary, has delivered an additional 5.5 million SPECTRUM® government re

January 28, 2014 17:15

LifeCell Corporation Acquires Advanced Adipose Tissue Injector

Kinetic Concepts, Inc. (KCI) announced today that LifeCell Corporation (LifeCell, www.lifecell.com/) has acquired an advanced adipose Tissue Injector (aTI) for improved fat grafting procedures from th

January 28, 2014 10:41

Quantum Biosystems Demonstrates First Reads Using Quantum Single Molecule Sequencing

Quantum Biosystems today announced the release of raw data access to its first reads. The company released reads showing an accuracy of more than 99% in non-homopolymer regions and homopolymer indels

January 27, 2014 20:00

AstraZeneca, DKFZ and EORTC Join WIN Consortium

The Worldwide Innovative Network (WIN) Consortium in personalized cancer medicine is proud to announce that AstraZeneca, DKFZ and EORTC have joined the Consortium. WIN is a unique global network of le

January 27, 2014 16:15

Catalent Files Registration Statement for Initial Public Offering

Catalent Pharma Solutions announced today that Catalent, Inc. has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public o

January 27, 2014 13:51

Saudi Arabian Medical Centers Select Vital as Its Enterprise Advanced Visualization Solution

Vital Images, Inc., a Toshiba Medical Systems Group Company and leading provider of advanced visualization and analysis solutions for healthcare providers, was selected by two leading university hospi

January 27, 2014 13:50

K2M Submits S-1 Draft Registration Statement for Proposed IPO

K2M Group Holdings, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 to the United States Securities and Exchange Commission (SEC) relating to the p

January 24, 2014 16:10

SecondOpinions.com, Featuring a State-of-the-Art Teleradiology and Telemedicine Platform, Introduces a New Global Feature Second Opinions Express TM

USARAD Holdings Inc, a leading US Joint Commission Accredited teleradiology and telemedicine solutions provider recently launched SecondOpinions.com which offers a state of the art, proprietary, web-b

January 16, 2014 08:25

KCI Negative Pressure Wound Therapy with Instillation Supplement Published in International Wound Journal

Kinetic Concepts, Inc. announced today the publication of a supplement, recently released in the International Wound Journal (IWJ), which outlines current wound care challenges and practices and prese

January 15, 2014 18:24

BioGaia: New Study Indicates It’s Possible to Prevent Colic in Healthy Infants

A study of 468 healthy newborns shows that infants given the probiotic Lactobacillus reuteri Protectis cried less than half as long as infants given a placebo. The infants given Lactobacillus reuteri

January 15, 2014 17:00

Quintiles Receives Technology Security Award from IDG’s CSO Magazine

Quintiles(http://www.quintiles.com/news) announced today that it has been named to the 2014 CSO40 by IDG's CSO magazine for the second year in a row, recognizing its “Trusted Cloud Services Model” whi

January 14, 2014 17:35

Biotoscana agrees to acquire United Medical to expand commercial presence in Brazil and create a leading regional specialty pharmaceutical company in South America

Grupo Biotoscana SL, a pharmaceutical company based in Bogotá, Colombia, and majority owned by Advent International and Essex Woodlands, today announced that it has signed an agreement to acquire Unit

January 10, 2014 11:40

First International Consensus Guidelines Published for KCI Negative Pressure Wound Therapy with Instillation

Kinetic Concepts, Inc. (KCI) announced today the publication of the first International Consensus Guidelines for its Negative Pressure Wound Therapy with Instillation (NPWTi).[1] The guidelines appear

January 09, 2014 16:50

Patients Get Safety Information, Pill Reminders with New Mobile App from Quintiles

Information about potential adverse reactions from multiple medicines and a pill reminder which can be set for hourly, daily or weekly alerts, are some of the features on a new mobile app created by Q

January 08, 2014 15:25

Quintiles’ Fourth Quarter 2013 Earnings Call Scheduled for Thursday, February 13th

Quintiles Transnational Holdings Inc. (NYSE: Q) will release its financial results for the fourth quarter of 2013 prior to its investor call on Thursday, February 13, 2014, at 8 a.m. EST to discuss fo

January 08, 2014 10:51

Astellas to Form Strategic Partnership With ClearPath To Build Vaccine Portfolio

Astellas Pharma Inc. (Astellas) and ClearPath Development Company (ClearPath) announced today a strategic partnership to form a portfolio of development companies focused on vaccines targeting infecti

January 08, 2014 09:42

ABRAXANE® Plus gemcitabine Receives European Marketing Authorization for First-Line Treatment of Patients with Metastatic Pancreatic Cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the European Commission (EC) has granted approval for ABRAXANE (paclitaxel formulated

News by Region

News by Industry